The Role of Mesothelial Cells in Liver Development, Injury, and Regeneration.
- Author:
Ingrid LUA
1
;
Kinji ASAHINA
Author Information
- Publication Type:Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Review
- Keywords: Glisson's capsule; Hepatic stellate cells; Liver fibrosis; Mesothelial-mesenchymal transition; Myofibroblasts
- MeSH: Epithelial Cells/*physiology; Epithelium/metabolism; Hepatic Stellate Cells/*physiology; Humans; Liver/*cytology/injuries/*physiology; Liver Cirrhosis/etiology/prevention & control; Liver Regeneration/*physiology; Mesenchymal Stromal Cells/physiology; Myofibroblasts/physiology
- From:Gut and Liver 2016;10(2):166-176
- CountryRepublic of Korea
- Language:English
- Abstract: Mesothelial cells (MCs) cover the surface of visceral organs and the parietal walls of cavities, and they synthesize lubricating fluids to create a slippery surface that facilitates movement between organs without friction. Recent studies have indicated that MCs play active roles in liver development, fibrosis, and regeneration. During liver development, the mesoderm produces MCs that form a single epithelial layer of the mesothelium. MCs exhibit an intermediate phenotype between epithelial cells and mesenchymal cells. Lineage tracing studies have indicated that during liver development, MCs act as mesenchymal progenitor cells that produce hepatic stellate cells, fibroblasts around blood vessels, and smooth muscle cells. Upon liver injury, MCs migrate inward from the liver surface and produce hepatic stellate cells or myofibroblast depending on the etiology, suggesting that MCs are the source of myofibroblasts in capsular fibrosis. Similar to the activation of hepatic stellate cells, transforming growth factor β induces the conversion of MCs into myofibroblasts. Further elucidation of the biological and molecular changes involved in MC activation and fibrogenesis will contribute to the development of novel approaches for the prevention and therapy of liver fibrosis.
